Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients Wi
- This topic has 32 replies, 8 voices, and was last updated 13 years, 1 month ago by
.
-
Posts
-
The trial contact information has not been activated. You might want to contact the Principal Investigator: Anthony B. El-Khoueiry, MD USC/Norris Comprehensive Cancer Center
Ph: 323-865-3967; 800-865-0102
Email: elkhouei@usc.edu.
This is a multicenter clinical trial therefore, I assume that you might be able to find a physician close to your Mom’s home. That is of course, if your Mom’s fits the criteria. Let me know if you need any help.
Regarding the off-label drug use: From what I understand, many cancer drugs are used off-label (if not most.) You might pose this question to another physician actively working with CC patients.
Good luck and please, keep us posted.
Best wishes coming your way,
MarionThanks so much for this info, Marion. Am having no luck getting through on either of the phone numbers…!
1. Basic question:
2. Can patients ever use these medications/drugs even if they are not participating in a trial? Meaning, what is the situation with off-label use of drugs? How can a patient get this?
In January, we did ask my mother’s Sloan-Kettering oncologist about these two drugs (anti-angiogenetics, if I remember correctly??)- and numerous others, older chemos, new things, all found in our research- he seemed reluctant to recommend any for her due to “side effects”???
3. Last, any basic tips on how to get into a trial???
Thanks so much!!!!!!!
- The forum ‘Clinical Trials’ is closed to new topics and replies.